Verastem (VSTM) logo

Verastem (VSTM) stock

Cancer medicines , market cap $864M

After-hours Fri
$6.39
+0.95%

Close $6.33 -7.73%

Why is VSTM down?

Down 30% from Nov 11 to Nov 20 while the S&P 500 fell 9%.

  • From Nov 11 to Nov 20, a change of officers was reported to the SEC on Nov 19, and cash covers about 4 quarters.

Sources: Price history, Nov 20, 2026; SEC filing, Nov 19, 2026; Latest balance sheet, Nov 5, 2026

Tell me next time VSTM moves

Free account, no card. An optional alert when VSTM moves or its score changes.Pro, $1 for a first month. An optional alert when VSTM moves or its score changes.Pro, 7 days free with a card. An optional alert when VSTM moves or its score changes.

Or see it live, free until Tuesday morning. No account.Or see one stock in full, free. No account.
1 more reason, free with an account →See every reason on VSTM →How the business stands, the timeline, and its peers, for Pro members.
Quality Score
0
Below Average
In its industry
#41of 89
Checks firing
1of 14
Trending up
From 52-week high
-41.5%
under its best in a year

VSTM's Quality Score fell 2 points on Fri, Nov 20, to 0. Its 6-month gain fell to 49%, under 52.5%, and its 12-month gain is under 88%.

Follow VSTM's trial news. Pro members can get an alert when Verastem files news, and see its trials, share raises, and its CEO's filings.

Get an alert when VSTM files news on its trialsSee it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

NextQ4 2026“…in pancreatic, lung and colorectal cancers, with three Phase 3 trials planned to initiate in late Q4 2026…”Trial start · SEC filing · Nov 5
Cash$173M, about 4 quarters at the last year's spendingOn Sep 30 · raised money since, not counted · the company says “into 1H of 2028”

Key facts on VSTM

Key facts on VSTM
Holding it back38.4% more shares than a year ago
Latest filing8-K, Nov 19 Reported a change of officers or directors

VSTM in the news

Fri Nov 6Verastem earnings missed by $0.25, revenue fell short of estimates Investing.com and 1 more VSTM closed −10.3% that day.

1 more big story on VSTM in the past 12 months, for Pro members.

What's next

Fri Dec 4: IASLC/ASCO North America Conference…Industry event · date confirmed.

Expected to report Wed Mar 3, after the close

After its last 4 reports it closed -0.5% on average, higher 2 of 4 times.

Cash$173M, about 4 quarters at the last year's spendingOn Sep 30 · raised money since, not counted · the company says “into 1H of 2028”

VSTM catalysts

Coming up

8 more coming up and 4 past catalysts since 2018, with sizes and sources, for Pro members.

What's next for VSTM, and how long its cash lasts

Next step the company has named

Q4 2026“…pathways – Three registration - directed Phase 2 trials underway in pancreatic, lung and colorectal cancers, with three Phase 3 trials planned to initiate in late Q4 2026/1H 2027”Trial start · SEC filing · Nov 5

What it means: when a trial begins, or reaches the stage the company named.

A trial underway
RAMP 301Phase 3 · Recruiting · 270 people · main data estimated Oct 15, 2028 · NCT06072781

9 more trials, 5 more milestones and 40 filings, for Pro members.

Cash runway Sep 30 balance sheet

About 4 quarters

$173M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into 1H of 2028” (8-K, Nov 5). It has raised money since that balance sheet, which is not counted here.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3ASR, filed Nov 5, 2026)
  • At-the-market share sales program (S-3ASR, filed Nov 5, 2026)

For Pro members: 3 raises and their amounts, and the share count against a year ago.

Insiders

CEO Dan Paterson sold 1,299 shares on Nov 3, under a planned sale. 10 more insider trades this year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and Dan Paterson’s 34 filings and quotes.

Get an alert when VSTM files news on its trialsA free account. No card.Pro: $1 first month.Pro, 7 days free with a card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

12 more FDA dates and 98 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 144 dates, ranked →See all 144 dates, ranked →Start Pro

Why VSTM scores 0

Below Averagefor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means

Well below its recent run. VSTM scores 0 today, against a median of 7 over its last 20 recorded sessions.

  • +3Growth sales up 650% on the year, gross margin up 4.4 points, from Massive's market dataSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • −2Dilution 38.4% more shares outstanding than a year agoNew shares over the year: -1 at 10% more, -2 at 25% more.
  • Chart checks adds
  • Run-up adds
  • Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
  • Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Long-term trend, Size, Profit, Persistence, and News.

What every line is worth, and the reason behind it, on VSTM and every other stock.Get in free →See the top 3 →Start Pro

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:34 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How VSTM ranks in Pharma

VSTM is #41 of 89 by Quality Score.

How VSTM ranks in Pharma
RankStockQuality Score
41Verastem (VSTM) logoVSTMVerastem0

More in Pharma

When does VSTM report earnings, and what happens after?

Expected to report Wed Mar 3, after the close (in 102 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

Close after the report, last 3

-13.6%+14.0%-10.3%
May 7Aug 6Nov 5
ReportedGapReaction5
days
Nov 5, 2026After close-7.7%-10.3%-10.0%
Aug 6, 2026After close+12.5%+14.0%+12.9%
May 7, 2026After close-3.7%-13.6%-16.8%

VSTM closed higher after 2 of its last 4 reports.

All 4 reports, and VSTM's Quality Score going into each

VSTM sales and profit by year

Sales and profit by year

Sales grew every year from 2021 to 2025, to $30.9M. It lost money in each of the four years.

VSTM has 1 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on VSTM, and all 14 on every stock.Get in free →See the top 3 →Start Pro

VSTM RSI on Nov 20: 27.6, below its 50-day, above its 200-day

Not scored

RSI 27.6, MACD below signal, below its 50-day, above its 200-day. Not scored.

The deep dive on VSTM

5 more findings on VSTM, each with its source, for Pro members.

VSTM share count over time

38% more shares than a year earlier.

Weighted shares, quarter to Sep 30, 2026, both from one filing

Shares of VSTM outstanding, as filed
Shares
outstanding
As
of
126MNov 2, 2026
90.6MAug 3, 2026
87.9MMay 4, 2026
87.8MFeb 27, 2026
Offerings, shelves, and splits of VSTM, from its filings
From its
filings
Filed
Registered shares for a later sale (S-3ASR)Nov 5, 2026
Priced a sale of sharesOct 14, 2026
Raised $61.9M in a sale of shares, about 7% of its market valueNov 17, 2025
Registered shares for a later sale (S-3)Aug 8, 2025

3 more offerings on file, for Pro members.

VSTM's officers and directors

Officers and directors with a Form 4 in the last 12 months.

4 more officers and directors file at VSTM.

See insider trades by person

Which ETFs hold VSTM?

In ETFs: VSTM is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Verastem

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

102 employeesNeedham, MAverastem.com

What Verastem says it competes with

“The biotechnology and pharmaceutical industries are characterized by rapidly advancing technologies, intense competition, and a strong emphasis on proprietary products.”

From its annual report, SEC filing · Mar 4, 2026

Here is what Pro members see.

  • The same page for Pro members, on Microsoft

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on VSTM and every other stock.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

  • What would turn VSTM's score around: 8 things
  • 12 more filings explained, a plain line each
  • Real-⁠time prices, no delay

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

Straight AnswersStraight Answers

As of Nov 21, 2026: VSTM's Quality Score is 0 (Below Average), #41 of 89 in Pharma.

What does VSTM's Quality Score say?

VSTM scores 0 today, which Breakaway calls Below Average. It is #41 of 89 in Pharma by Quality Score, with 1 of 14 chart checks firing. Down 30% from Nov 11 to Nov 20 while the S&P 500 fell 9%. Cash lasts about 4 quarters at its spending (to Sep 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is VSTM's Quality Score?

VSTM scores 0 today, which Breakaway calls Below Average (0 to 5). That is #41 of 89 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind VSTM's 0.

When does VSTM report earnings?

Expected to report Wed Mar 3, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. VSTM closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See all 3,170 stocks rankedSee all 3,170 stocks rankedStart Pro

See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.

What's next for Verastem: from its SEC filings and ClinicalTrials.gov, the company's words, the registry's dates, and arithmetic, not a forecast. Companies often miss the dates they set.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.